6-Substituted-arylpyrido(2,3-d)pyrimidin-7-amines, derivatives and salts thereof, pharmaceutical compositions containing any of the foregoing, and processes for producing any of the foregoing
申请人:WARNER-LAMBERT COMPANY
公开号:EP0018151A1
公开(公告)日:1980-10-29
6-Substituted-arytpyrido[2,3-d]pyrimidin-7-amines and derivatives are disclosed which have the following formula:
wherein R, and R2 are hydrogen or alkyl; R4 is halogen or alkyl; R5 and R6 are hydrogen, haloaen or alkvl: R3 is H2N-,
= N-, CH3-SO2-NH- or CH3-NH-C-NH-; R is hydrogen, alkyl, haloalkyl, alkoxy, alkoxymethylene, mono- or dialkylamino, trifluoromethyl, furyl, pyridyl or phenyl; R7 is hydrogen or alkyl; and Rs is hydrogen or alkylamino.
The foregoing compounds, and pharmaceutically acceptable acid addition salts, as well as pharmaceutical compositions containing such compounds or salts, are useful in the treatment of hypertension. Processes for producing the compounds are also disclosed.
本发明公开了具有下式的 6-取代-芳基吡啶并[2,3-d]嘧啶-7-胺及其衍生物:
其中 R 和 R2 是氢或烷基;R4 是卤素或烷基;R5 和 R6 是氢、卤素或烷基:R3是H2N-、
=N-、CH3-SO2-NH-或 CH3-NH-C-NH-;R 是氢、烷基、卤代烷基、烷氧基、烷氧基亚甲基、单或二烷基氨基、三氟甲基、呋喃基、吡啶基或苯基;R7 是氢或烷基;Rs 是氢或烷基氨基。
前述化合物、药学上可接受的酸加成盐以及含有此类化合物或盐的药物组合物可用于治疗高血压。还公开了生产这些化合物的工艺。